Sponsored Events

 

Contract-Biotechnology.com is routinely participating in international partnering and conferences. The following event are sponsored by Contract-Biotechnology.com


International Translational and Regenerative Medicine Conference April 25-27, 2018 Rome, Italy.

Organizer: Madridge Publisher Event Website: http://itmc.madridge.com/ Contact person: Samatha R,  itmc@madridge.com Phone: +1-302-231-6959International Translational and Regenerative Medicine Conference (ITMC-2018) conference includes - Areas of research that aims to improve human health and longevity by determining the relevance to human diseases through novel and scientific discoveries available for practical application, especially in relation to biological sciences, life sciences, medicine and engineering. ITMC-2018- It aims to discover advances in health practice, management and education in relation to health disparities as well as a breadth of other topics - Need for translational medicine, Challenges in translational medicine, Opportunities in translational medicine. ITMC-2018 conference includes Plenary lectures, Keynote lectures and short courses by eminent personalities from around the world in addition to contributed papers both oral and poster presentations. Conference mainly focuses on:Translational medicine approaches in drug discovery & development, Drug Design & Delivery, Translational cardiology and vascular medicine, Translational research in blood disorders, Translational therapeutics/ Novel therapeutic technologies, Clinical and Translational Oncology, Pharmacology (Cancer / Clinical), Medicinal genetics, Bio Molecular/ Nuclear imaging, Biomedical sciences / Bioengineering, Stem cells/ regenerative medicine, Tissue engineering, repair and regeneration, Cancer research and regenerative medicine, Cell & Gene therapy, Nanofibers/ Nanomedicine in regenerative medicine, Scaffold in regenerative medicine, Advances in stem cells and regenerative medicinePlease mail us at: itmc@madridge.com Submit your abstracts at: http://itmc.madridge.com/abstract-submission.php


SMi’s Pain Therapeutics Conference 21 – 22nd May 2018London, UK

http://www.pain-therapeutics.co.uk/Contrbio

Each year SMi brings together decision makers and creative thinkers to unite and collectively shape and discuss the new breakthrough discoveries, innovations fuelling the future development of the Pain Therapeutics landscape.Attendees of the Pain Therapeutics Conference will be able to network with industry experts from leading pharma companies, biotech and academics to name but a few.

Explore novel targets for pain therapeutics, new translational approaches and pipeline drug development.

 For further information and book your place, visit http://www.pain-therapeutics.co.uk/Contrbio

 


The Microbiome Invest Congress 2018 is dedicated to showcasing the most innovative emerging companies and academics with commercially viable research that manipulates the microbiome. Active investors, and multi-national nutrition and pharmaceutical companies will also share their knowledge and perspectives on commercialisation and discuss the most cutting-edge products and research in the microbiome space. Register now to make sure you make the right connections as an investor, biotech, start-up or pharma compan.

More information at the website of The Microbiome Invest Congress 2018 


The average consumer spends $5 a day on skincare, whilst using up to 515 synthetic chemicals daily to eradicate dermalogical concerns - how can this be good for skin?

Introducing the Skin Microbiome Congress. Join 100+ industry experts from multinational pharmaceutical, beauty and personal care companies, independent skincare brands and innovative biotechs to discover the potential of prebiotic, probiotic and postbiotic products being developed to protect and promote a healthy microbiome and combat dermatological conditions.Hear from Gallinée, Dermala, The Jackson Laboratory, Biomillenia, Johnson & Johnson and more as they unlock the potential of skin microbiome. Take advantage of:

 Effective Networking – Take advantaged of 15+ dedicated networking hours

 Cutting Edge Research – Discover advancements in therapeutic & cosmetic products containing live bacteria, bacterial extracts, or active ingredients

 Consumer Trends - Understand how consumers trends towards natural, organic products and active beauty are shaping product evolution

 Clinical Trials – Explore how to design an effective clinical trial & translate research into clinically & commercially viable therapeutics

 Competitive Edge – Determine how to differentiate your product line & seize this market opportunity with scientifically backed products

Regulation – Understand the paths to market & regulatory considerations to launch a cosmetic or therapeutic product   Find out more 


Join Oxford Global’s 19th Annual Drug Discovery Summit on the 7- 8th June 2018 in Berlin, Germany to explore the latest innovations pushing industry to new heights. This congress will cover such areas as innovation, enabling technologies, new modalities and novel drug targets as well as covering key areas such as phenotypic screening, genome based drug discovery and small molecule drug discovery.  Bringing together over 300 senior level peers, the congress is once again co-located with our 6th Annual Discovery Chemistry and Drug Design Congress. Delegates can expect to hear updates on discovery, medicinal and computational chemistry as well as medicinal chemistry in drug design. New for 2018 we’ll be including deep dive sessions on DNA encoded libraries as well as presentations on data visualisation, protein-protein interactions and protein degradation.     View Agenda: http://bit.ly/2mqWK5m


Oxford Global is proud to present the 2nd Annual Microbiome Discovery and Development Congress, taking place on the 7-8th June 2018 in Berlin, Germany.  The conference showcases world-class senior industry experts presenting case studies on the most exciting issues in the microbiome field, covering novel strategies in microbiome research, the latest therapeutic trends, and the challenges and opportunities involved in commercialising microbiome therapeutics. View Agenda: http://bit.ly/2BOsODK  The congress will cover 3 areas focusing on:  

  • Novel Strategies & Technologies for Microbiome Drug Discovery  

  • Therapeutic Potential of the Microbiome  

  • New for 2018! Workshop on commercialising microbiome therapeutics.


SMi’s 2nd Annual Pharmaceutical Microbiology West Coast

Delivering updates and promoting discussion on key challenges and developments within the pharmaceutical microbiology industry 

Conference: 7th  - 8th June 2018

Workshops: 6th June 2018

Location: Crowne Plaza, San Diego, CA, USA   www.pharma-microbiology-usa.com/contractbio  


SMi proudly presents the 2nd Annual Pharmaceutical Microbiology West Coast Conference, in San Diego, USA, on the 7th and 8th June 2018.


The pharmaceutical microbiology field is an ever-present constant in almost all areas of pharmaceuticals. Therefore, professionals within the field need to be informed and updated on the revised regulations and newly emerging methods and practices.

Join us to discuss and address the evolving issues facing this industry, such as: the aseptic practice and contamination prevention, mycoplasma testing, water monitoring and biofilms.This event is CPD accredited.

 

Sponsored by Associates of Cape Cod Inc, BiomerieuxCharles RiverFujifilm Wako Chemicals US Corporation, Mettler Toledo, MilliporeSigma and Roche  

 

Early bird offers available! For further details on speakers and to register, visit the website at www.pharma-microbiology-usa.com/contractbio  or contact the team at +44(0) 207 27 6000!


 

Bio-Banking 2018 13-14 June 18 Holiday Inn, Kensington Forum, London, UKhttps://www.smi-online.co.uk/pharmaceuticals/uk/conference/biobanking


This year marks SMi’s 8th annual conference on Biobanking which will take place on 13th & 14th June 2018 in London, United Kingdom. The event will bring together internationally recognised biorepositories, scientific pioneers from pharmaceutical companies, and academics to strengthen current knowledge in biosample management and their research applications. Further, the event will dive into application of novel technologies and security software associated to the protection of data.The conference will aim to broaden the understanding of the ethical and regulatory frameworks, as well as defining the impact that the General Data Protection Regulation (GDPR) will have in 2018. The conference also aims at defining some amongst the most successful applications of biosamples in the market. Speakers are the result of a careful selection of experts in the industry and will include: directors of biorepositories, professionals working in regulatory agencies, drug discovery program directors and legal advisors.Join us in June to take part in cutting-edge discussions through a series of interactive presentations, panel discussions and case-studies addressing all the critical issues regarding the improvement of Biobanking: a market that is expected to reach USD 2.69 Billion by 2022 from USD 1.85 Billion in 2017, at a CAGR of 7.8%.*

 


 

ADMET

Exploring the optimisation of ADMET modelling techniques, preclinical DMPK applications and development of biopharmaceuticals

Location: Holiday Inn Kensington Forum, London, UK     www.admet-event.com/contractbio    

CHAIR: Eric Bloome, Vice President, Global Pre-Clinical Safety Senior Research Fellow, AbbVie

SMi is delighted to announce the 13th annual ADMET conference returning to London on the 9th - 10th July 2018, featuring.  Developments in ADMET and novel technologies determine the properties of a drug candidate in the preclinical stage of drug discovery. Poor ADMET properties are the principal cause for a candidate to fail at any stage of drug development. ADME-Toxicology and Pharmacokinetic studies are the key strategic check-points for pharmaceutical companies to reduce drug discovery cost and minimise production times.  The growing use of ADMET technologies is driving the market growth, which is estimated to reach $14,319.9 Million by 2022, with a CAGR of 10.6% from 2016 to 2022*. The main objective of early prediction of ADME properties of a compound is to increase the success rate of it reaching the development stage.  *Source: http://bit.ly/2hMJcgU  This event is CPD accredited.    

 Early bird offers available!      For speaker line-up, further details and to register, visit the website at www.admet-event.com/contractbio or contact the team at +44(0) 207 827 6000


 

Molecular Diagnostics Evaluate the future of diagnostics for rapid detection and improved clinical outcomes

Conference:  Monday 9th – Tuesday 10th July 2018

Workshops: Wednesday 11th July 2018

Location: Holiday Inn Kensington Forum, London, UK  www.molecular-diagnostics-conference.com/contractbio

Co-Chairs:David Crosby, Cancer Research, UK Hugues Malonne, Director General, DG Post Autorisation, Federal Agency for Medicines and Health Products Belgium.

SMi is proud to announce their 5th Molecular Diagnostics conference. The event will take place in central London on Monday 9th and Tuesday 10th July 2018, along with two half-day post-conference workshops taking place on Wednesday 11th July 2018. The global molecular diagnostics market is forecasted to reach over US$10 billion in the next three years, at a CAGR of 9.1% from 2016 to 2021*. In an ever-evolving universe of molecular diagnostics, it is vital to keep up with emerging and developing technology, products and applications. Furthermore, companies must comply to the constantly change regulatory environment and tackle the challenging process if implementing these regulations.SMi welcomes you to explore the expanding market opportunities, the least diagnostics advancements and regulatory requirements at the 5th Molecular Diagnostics Conference.This event is CPD accredited.

EARLY BIRD-RATES AVAILABLE     For speaker line-up, further details and to register, visit the website at www.molecular-diagnostics-conference.com/contractbio or contact the team at +44(0) 207 827 6000.


September 25-27, 2018 Seville, Spain https://www.biospain2018.org/

 

BIOSPAIN is the largest biotech event organized by a national bioindustry association in Europe and one of the largest in the world by the number of one-to-one meetings (+3.000) and companies participating (+800). 34% of our delegates came from outside of Spain.

BIOSPAIN is organized by ASEBIO, the Spanish Bioindustry Association and each edition is co-organized by a local institution from the host city/region. On the 2018 edition, Biospain is co-organized by the Government of Andalucia through IDEA Agency. 

Some data about the 8th edition of BIOSPAIN held in Bilbao (Spain) were:

 

·         46 investors have attended the eigth edition of Biospain, including Edmond de Rothschild Investment Partners, Forbion, Johnson & Johnson Innovation, Novartis Venture Fund, Ysios Capital Partners, Caixa Capital Risc and Cross Road Biotech. 

·         Biospain 2016 further consolidates its position as the fifth biggest event for business meetings, with 2,970 one-to-one meetings taking place.

·         The event was attended by 1,750 individuals and 701 entities from 29 countries, meaning there was an international presence of 28%.

·         233 exhibitors came together for the event, with more exhibition space than at the previous edition.  

·         84.81% of survey respondents claimed to have identified real business opportunities. 

 

  


International Neurology Conference, December 03-05, 2018, Valencia, Spain
Email: neurology@madridge.com Website: http://neurology.madridge.com/

International Neurology Conference is going to be held during December 03-05, 2018, Valencia, Spain with main theme but not limited to: Neurology and Neurosciences with main focus on Integrative Systems, Central Nervous system and Imaging Techniques.. Neurology-2018 Participants has a wide choice of selection in the scientific sessions which include Neuro technology, Research and Development, Immunology, Neural Engineering, Neurocardiology, Case reports, Pharmacology, Toxicology, Ophthalmology, Physiology, Therapeutics, Nanotechnology applications, Oncology, psychology, Paediatrics, Genetics, Radiology and Imaging studies, Epidemiology etc.. Neurology-2018 conference includes Plenary lectures, Keynote lectures and short courses by eminent personalities from around the world in addition to contributed papers both oral and poster presentations.Targeted Audience:Vice Presidents/Senior Vice Presidents/Executive Vice Presidents, Heads/Leaders/Deans/Senior Professors/Associate Professor/Assistant Professors, Training Institutes, Manufacturing Medical Devices Companies, Clinical Data Management Companies, Machinery Manufacturing Companies, Medical Devices Manufacturing Companies, Neurovaccine Developers and Investigators, Associations and Societies, Business Entrepreneurs, Scientists and Researchers

Abstract Submission Opens:

January 15, 2018 – November 03, 2018

Earlybird Registration:

February 08, 2018 - March 15, 2018

Standard Registration:

March 16, 2018 - December 03, 2018

List of organizing committee members:http://neurology.madridge.com/committee.php We invite Associations/Societies/ Companies to the conference and become a partner and explore your knowledge and grow network with the peers. For any further query please mail us to neurology@madridge.com 


To arrange a meeting, please contact us and we will arrange a mutually convenient time.